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Abstract Oligopeptides derived from the gag polyprotein 
(Pr55 gag) of human immunodeficiency virus type 1 (HIV-1) 
segment were used to evaluate the extension of the putative 
binding region for the complex of Pr55 gag and the human 
cytosolic peptidyl prolyl cis/trans isomerase (PPIase) 18 kDa 
cyclophilin (Cypl8). Five N-terminally acetylated, C-terminally 
amidated oligopeptides containing one (HIV-1 Gag218-224; 1), 
two (HIV-1 Gag 21s-226 and HIV-1 Gag217-224; 2 and 3, 
respectively), three (HIV-I Gag217-226; 4) or four (HIV-1 
Gag213-237; 5) proline residues were synthesized. Using competi- 
tion experiments with a standard substrate the binding affinities 
to Cypl8 of the synthesized peptides were determined. The ICs0 
value of 184 ~M for the 25-mer peptide 5 was fivefold or more 
lower than those of the peptides 1--4 lacking one or more prolines. 
Failure of competition in assays containing enzymes of other 
PPlase families by millimolar concentrations of 5 revealed a 
Cyp18 specific interaction involving the active site of the enzyme. 
In its far UV circular dichroism, aqueous solutions of 5 display 
properties of random coil conformation, but spectra were also 
consistent with a small contribution of proline specific secondary 
structures. However, a proline-rich peptide typical of forming 
left-handed polyproline II helices did not compete for the active 
site of Cypl8. The results demonstrate that the putative binding 
region of HIV-1 gag polyprotein has a certain degree of binding 
affinity to the PPIase site of Cypl8, and may add a previously 
unrecognized topological component to the known subsite 
specificity of cyciophilins. 
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Abbreviations: Cypl8, human recombinant cytosolic yclophilin with 
molecular mass of 18 kDa (according to Fischer, G. (1994) Angew. 
Chem. Int. Ed. Engl. 33, 1415 1436); PPIase, peptidyl prolyl cis/trans 
isomerase; FKBP, FK506 binding protein; CsA, cyclosporin A; HIV- 
1, human immunodeficiency virus type 1; SIV, simian immunodefi- 
ciency virus; NMR, nuclear magnetic resonance; TFA, trifluoroacetic 
acid; DCM, dichloromethane; DIEA, N,N-diisopropylethylamine; 
DMAP, N,N-dimethylaminopyridine; Fmoc, 9-fluorenylmethoxycar- 
bonyl; GdmC1, guanidinium hydrochloride; HBTU, O-(benzotriazol- 
l-yl)-l,l,3,3-tetramethyluronium hexafluorophosphate; HATU, 0-(7- 
azabenzotriazol- 1 -yl)- 1,1,3,3-tetramethyluronium hexafluorophos- 
phate; HOAr, 1-hydroxy-7-azabenzotriazole; HPLC, high perform- 
ance liquid chromatography; MBHA, 4-methylbenzhydrylamine; 
NMP, N-methylpyrrolidone; tBu, tert.-butyl; Trt, trityl; HOBt, l- 
hydroxybenzotriazole; Pmc, 2,2,5,7,8-pentamethylchroman-6-sulfon- 
yl; Ac, acetyl; CE, capillary electrophoresis; CA, capsid protein of 
HIV-I ; GST, glutathione S-transferase 
1. Introduction 
Previous reports have shown the lower incidence of devel- 
oping AIDS for HIV + patients who received immunosuppres- 
sive therapy with cyclosporin A (CsA) after organ transplan- 
tation [1-3]. Moreover, in response to the immunosuppressive 
drugs CsA and FK506, the growth of cells chronically infected 
with HIV-1 and HIV-2 was selectively inhibited [4]. After 
identifying two host cell cyclophilins (Cypl8 or Cyp23sec) in 
binary complexes with Gag polyprotein precursor Pr55 gag of 
HIV-1 the molecular causality underlying the CsA effect be- 
came more obvious [5]. CsA enables complex dissociation by 
its high affinity to cyclophilins. Obviously, the antiviral effect 
of CsA has to be due to a pathway distinct from irnmunosup- 
pression because CsA derivatives with negligible immunosup- 
pressive activity but high affinities for the active site of Cypl8 
retain potent anti-HIV activity [6-12]. 
Cyclophilins, the cellular receptors for CsA [13], are known 
to possess peptidyl prolyl cis/trans isomerase (PPIase) activity 
[14]. This enzyme activity seems to improve the correct iming 
of those protein folding events in which a cis/trans Xaa-Pro 
isomer distribution transiently does not correspond to the 
thermodynamic equilibrium but reflects the immediate sur- 
rounding of the polypeptide chain. 
Recently, it was shown that Cypl8 is required for HIV-1 
infectivity prior to reverse transcription but subsequent to 
receptor binding and membrane fusion [15]. Incorporation 
of Cypl8 into HIV-1 virions occurred via contact with a pro- 
line-rich segment of the capsid domain of Pr55 g~g [16]. This 
conserved array totalling four prolines occurs in the periodic- 
ity (P(X)4p~22(X)2P(X)sP). Prolines are preferentially flanked 
by glycine and charged amino acids. Mutant proteins of the 
HIV-1HxB2, having site-directed mutations, P222A or G221A, 
failed to bind on GST-CypI8. Virions equipped with these 
proteins cannot sequester Cypl8 into the released virions 
[15,16], emphasizing the importance of the Gly221-Pro 222 
bond for Pr55g'~g/Cyp18 complex formation. With respect o 
Cypl8 packaging, P225A behaves like wild type devoid of 
forming a defective viral phenotype. Similarly, protein var- 
iants P217A and P231A retain Cypl8 binding. Analogously, 
small in-frame deletions in the capsid domain of Pr55 gag dras- 
tically decrease Cypl8 packaging into viral particles [7]. 
However, it is not known whether or not catalysis of prolyl 
bond isomerization in Pr55 gag plays a role in the Pr55gag/ 
Cypl 8 mediated enhancement of HIV-1 infectivity. Moreover, 
the finding of a stable Pr55gag/Cyp18 interaction is at variance 
with the known weak binding of proline-containing peptides 
to the active center of Cypl8 [17]. 
In order to evaluate whether the four prolines module of 
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HIV-1 Pr55 g~g represents a high affinity module for the active 
site of Cypl8,  we synthesized five oligopeptides derived from 
the capsid domain of Pr55 gag including throughout the essen- 
tial Gly221-Pro 222 peptide bond:  
1 Ac-VHAGPIA-NH2 
2 Ac -VHAGPIAPG-NH2 
3 Ac -PVHAGPIA-NH2 
4 Ac -PVHAGPIAPG-NH2 
5 Ac -DRVHPVHAGPIAPGQMREPRGSDIA-NH2 
In peptide 4, three proline residues in central position are 
combined, and finally, peptide 5 assembled the conserved four 
prolines in conjunction with the N- and C-terminal flanking 
sequences, hydrophil ic in their nature. The peptides were 
synthesized with both acetylated and amidated termini 
thought to mimic more likely the binding module of the 
Pr55 g~g polypeptide chain. All compounds were applied to 
an assay for PPIase activity of Cypl8 to determine their abil- 
ity to compete with a substrate containing a single proline 
residue. These investigations were complemented by measur- 
ing proline-rich peptides known as typical ligands of SH3 or 
WW domains with Kd values in the ~tM range. For evaluating 
enzyme specificity of binding, we analyzed the interaction of 
the peptides 1-5 with members of other PPIase families. This 
major result implied an unexpected strong and selective bind- 
ing of peptide 5 at or near the active site of Cypl8. 
2. Materials and methods 
2.1. Peptide synthesis 
Fmoc-amino acids were purchased from Alexis (Gr/dnberg, Ger- 
many). All chemicals and solvents were of analytical grade and were 
used without further purification. As an exception diethylether was 
distilled from sodium and stored over KOH. 
All syntheses were carried out using a semiautomatic ACT 90 pep- 
tide synthesizer and Rink amide-MBHA resin (Novabiochem, Bad 
Soden, Germany; 0.55 mmol/g, 400 mg). HBTU/HOBt/DIEA activa- 
tion of N~-Fmoc-protected amino acids (5 equiv.) was employed for 
coupling in the case of peptides 1--4 and HATU/HOAt/DIEA activa- 
tion in the case of peptide 5 (t0 equiv.). The side-chain protecting 
groups used in all syntheses were tBu for Ser, Asp, Glu; Trt for His, 
Gln; and Pmc for Arg. The coupling reactions were performed in 
NMP. Initially, chain elongation was associated with the reaction 
time of 5 min for the Fmoc deprotection in 20% piperidine in 
NMP, but it gradually increased to 20 min when the number of amino 
acids of the chain bound to the resin was increased up to 10 residues. 
A double deprotection strategy was used at each step to ensure com- 
plete deprotection. Final acetylation was carried out using acetanhy- 
dride (10 equiv.), DIEA (10 equiv.) and DMAP (0.5 equiv.) in NMP. 
Following acetylation the resin was washed twice with NMP; DCM; 
iso-propanol and diethylether and dried carefully. 
The peptides were cleaved from the resin using 95% TFA. The 
crude peptides were precipitated from iso-propanol solution using 
diethylether. The methionine containing peptide 5 was treated with 
trimethylsilylbromide to remove methionine S-oxide. All peptides 
were purified by preparative RP-HPLC using a Sycam apparatus 
equipped with a Merck LiChrosorb RP8 (250 × 25 mm, 7 ~xn, flow 
rate 20 ml/min, detection wavelength 215 nm) column or a Macherey- 
Nagel Nucleosil 300 RP4 (250× 10 mm, 7 lam, flow rate 10 ml/min; 
detection wavelength 210 rim) column and 5-40% aqueous acetonitrile 
containing 0.05% TFA gradient. The product containing fractions 
were evaporated in vacuo to remove acetonitrile and lyophilized yield- 
ing white powders. The purity of each final product was assessed by 
analytical RP-HPLC using a Sycam Nucleosil 100 RP18 (250X4 mm, 
5 ~tm, flow rate 1 ml/min; detection wavelength 210 nm) and by 
capillary electrophoresis (Applied Biosystems model 270A-HT, 30 
kV, 30°C, hydrodynamic njection for 2 s/5"Hg, fused silica capillary, 
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uncoated, 72 cm×50 ]am, ~: 200 nm, 70 mM sodium citrate pH 2.3). 
All peptides were characterized by TOF-MALDI-MS and by 1H- 
NMR spectroscopy (Bruker ARX 500 spectrometer at 500.13 MHz). 
2.2. Determination of the IC5o values 
All measurements were performed on a Hewlett-Packard 8452A 
diode array spectrophotometer with a thermostatted cell holder. Con- 
stant temperature was maintained within the cell (d= 1 cm) by water 
circulated from a Cryostat Haake D8 (Haake Fisons, Germany). The 
Hewlett-Packard 89531A MS-DOS-UV/VIS operation software or 
SigrnaPlot Scientific Graphing System Vers. 2.00 (Jandel Corp., 
USA) was used for data analysis. The concentration of enzymatically 
active Cypl8 was determined using fluorometric titration with CsA 
assuming that inhibitor binding reflects an unperturbed active site 
[13]. Typical purity was above 70% active enzyme leading to a k~tl 
Km value of 1.5 × 107 s -1 M -1 for Suc-Ala-Ala-Pro-Phe-NH-Np. All 
stock solutions were filtered through a 0.45 mm PVDF membrane 
(AllTech, Unterhaching, Germany). Measurements of the bimolecular 
rate constants k~t/Km for the PPIase catalyzed isomerization i  the 
absence and the presence of the proline-containing peptides were per- 
formed utilizing a solvent assisted shift in the cis/trans equilibrium [18] 
of Suc-Ala-Ala-Pro-Phe-2,4-difluoroanilide afterjumping into the fi- 
nal buffer solution at 240 nm. Typically, a mixture of (1240-x) lal 
buffer, 5 ~1 BSA stock solution (5 mg/ml in 35 mM HEPES pH 7.8) 
and 5 lal PPIase stock solution was treated with x/al proline-contain- 
ing peptide solution reaching final peptide concentrations up to 1.5 
mM and incubated for 4 min at 10°C. Reactions were started by 
addition of 2 ~tl of the mentioned substrate stock solution (60 mM). 
Plot of residual PPlase activity versus peptide concentration was used 
to calculate the IC50 values of 1-5. All measurements were performed 
in duplicate. 
2.3. Determination of the steady-state parameters kc~t and Km of 
Suc-Ala-Gly-Pro-Phe-NH-Np 
The substrate Suc-Ala-Gly-Pro-Phe-NH-Np was purchased from 
Bachem (Heidelberg, Germany). The steady-state parameters became 
available by the improved protease coupled assay devised by Kofron 
et al. [19]. The measurements were performed by monitoring the ab- 
sorbance of released 4-nitroaniline at 390 nm (e = 11 814 M -1 cm -1) 
on a Hewlett Packard 8452A diode array spectrophotometer accord- 
ing to Schutkowski et al. [20]. Absorbance data points from each 
progress curve were analyzed by nonlinear least-squares optimization 
of Km and k~t in the differential equation d[C]/dt = -ko[C]-  V,,~x[C]/ 
(Km+[C]) using the software TREND, version 1.2 (Martin-Luther- 
University, Halle-Wittenberg, Germany). The resulting initial rates 
were fitted by nonlinear least-squares optimization of Km and Vm~x 
in the Michaelis-Menten equation v0 = Vm~[Co]I([Co]+Km). 
2.4. CD spectroscopy 
CD data were collected on a Jasco J-710 spectropolarimeter (To- 
kyo, Japan) interfaced to a personal computer. If not otherwise stat- 
ed, far UV measurements were carried out in a thermostatted quartz 
cell of the cylindrical 0.1 cm path length using 10 mM sodium phos- 
phate buffer pH 7.5 at 10°C. Baselines for all spectra were corrected 
by subtracting baselines for the appropriate solutions without peptide. 
Jasco software version 1,33.00 was used to calculate molar ellipticity 
based on the supplied sample molarity and cell path length. Usually, 
15-20 transients were obtained to improve the signal to noise ratio. 
Temperature dependence of the CD signals was investigated using the 
AVIV CD-Spectrometer 62A DS. Data recording occurred in the 
range 15 85°C with a step width of I°C. Equilibration time at each 
temperature was 0.7 rain (heating rate: 100°C/min), the time constant 
for data sampling was 12 s. 
3. Results 
3.1. Conformational homogeneity 
Due to the different number of proline residues the covalent 
structure of the peptides I -5  provides the potential for 2-16 
(2 n) cis/trans isomers. Slow interconverting cis/trans isomers 
were shown to lead to peak multiplicity in RP-HPLC [21,22] 
and capillary electrophoresis [23,24] since there is a difference 
in the migration time of the isomers. Differentiating minor 
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Fig. 1. Capillary zone electrophoresis of purified peptide 5 using an 
uncoated fused silica capillary (72 cm×50 gm) and 70 mM citrate 
buffer, pH 2.3. Conditions: constant voltage: 30 kV (resulting cur- 
rent: 21 /.tA), T: 30°C, ~,: 200 nm. 
peaks of c&/trans conformers from those resulting from im- 
purities usually inherent in solid phase peptide synthesis be- 
comes increasingly difficult when chain length increases. How- 
ever, as could be shown by RP-HPLC and CE, even in the 
case of the 25-mer peptide 5 the purity of the crude products 
was surprisingly high (> 80%). After a two-step purification 
by HPLC using an RP-8 and an RP-4 column peptide 5 was 
chemically homogeneous as could be demonstrated by both 
~H-NMR spectroscopy and capillary electrophoresis (Fig. 1). 
Remarkable is the fact that for peptides 1-5 at 25°C neither in 
HPLC (data not shown) nor in capillary electrophoresis ana- 
lyses could any proline-mediated peak splitting or widening be 
observed. Given a difference in the migration time of most 
isomers theoretically possible, this result may indicate the pre- 
dominance of a single proline isomer in solution due to en- 
ergetic stabilization by structure formation. Alternatively, the 
results can be explained by isomerization rates larger than 
0.05 s I at 25°C [23]. 
3.2. Kinetic competition experiments 
Binding to the active site can be detected by incubating 
mixtures of peptides 1-5 and a PPIase substrate with Cypl8 
with the consequent competition kinetics in an activity assay. 
However, in the standard PPIase assay the presence of a help- 
er protease leads to rapid degradation of several proline pep- 
tides used here (data not shown), thus preventing any pro- 
tease-coupled analytics [25]. To circumvent this limitation we 
used a protease-free assay system taking advantage of a sol- 
vent assisted shift in the cis/trans equilibrium [18] of Suc- 
Ala-Ala-Pro-Phe-2,4-difluoroanilide. After a solvent jump 
the time-course of cis/trans isomerization follows a first- 
order reaction characterized by the rate constant kobs = 
kcis~tran.~+ktrans-.cis. The catalytic activity of Cypl8 and other 
PPIases toward this substrate was evaluated in the pres- 
ence of different concentrations of peptides 1-5 by calculat- 
ing first-order rate constants for the accelerated isomerization. 
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Since the substrate concentration i the assay was 96 gM, it 
ranges well below the Km value of >--0.8 mM measured for this 
substrate composed by an equilibrated mixture of cisltrans 
conformers (unpublished ata). In contrast o the sole pres- 
ence of the cis isomer of the substrate in proteolytic assay, 
the non-proteolytic assay contains a mixture of cis/trans iso- 
mers for all peptides involved. Assuming zero enzyme activity 
toward the anilide substrate for Cypl8 completely saturated 
with the competitor peptides, IC50 values of peptides 1-5 were 
obtained by plotting residual PPIase activities versus peptide 
concentration (peptide 5; see Fig. 2). The solid line in Fig. 2 
represents he theoretical curve yielded from the rate equation 
for competitive inhibition and the IC50 value calculated. 
For peptides 1-5 the IC,~0 values are summarized in Table 1. 
All peptides were able to compete with the assay peptide for 
the active site of CyplS, irrespective of whether these com- 
pounds act as alternative substrates or as inhibitors. The tab- 
ulated IC~ values are significantly lower than the Ki values 
estimated for the uniform proline peptides AAPF, AAPA and 
AAPAA. Even in the presence of 5 mM of the latter tetra- or 
pentapeptides, inhibition of Cypl8 mediated isomerization of 
cis Suc-Ala-Ala-Pro-Phe-NH-Np was less than 10% [26]. In 
contrast, the binding affinity of the 25-mer peptide 5 for 
Cypl8 is particularly high, even if the number of prolines 
involved in contacts is still an open question. However, the 
number of prolines in the competing peptides does not play a 
major role for affinity because the proline-rich peptides Ac- 
RALPPLPRY-NH2 and Ac-ATPPPLPPPL-NH2 have no de- 
tectable ffect on the isomerization kinetics in concentrations 
of up to 0.8 mM in our assay. 
Furthermore, we measured whether peptide 5 would allow 
an even better fit into the active site of members of other 
PPIase families like human FKBP12, E. coli parvulin and E. 
coli trigger factor. The latter two enzymes remain completely 
unaffected by 5 in the assay, whereas the interaction with 
FKBP12 is characterized by the high IC50 value of 1.6 mM. 
The results shown in Table 1 gave rise to the assumption that 
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Fig. 2. Inhibition of Cypl8 by peptide 5, measured using the pro- 
tease-free assay described in Section 2. 
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Fig. 3. Comparison of the CD spectra of the following peptides: 
Ac-RALPPLPRY-NH2 (solid line), peptide 5 (dotted line), peptide 
3 (dashed line), peptide 4 ( ....... ), peptide 2 ( - - )  and peptide 1 
( ....... ) measured in 10 mM phosphate, pH 7.5 at 10°C, d= 1 ram, 
at a scan speed of 100 nm/min (response 0.5 s). Raw data of 16 ac- 
cumulations were noise reduced by Fourier transformation, 
CyplScy all four proline residues of the proline array of HIV- 
1 Pr55 gag have to be combined within one molecule. 
3.3. Structural properties o f  peptides 1--5 
At first glance, the circular dichroism (CD) spectra of pep- 
tides 1-5 in the far UV region at pH 7.5 and 10°C do not 
differ greatly from each other by expressing minima centered 
at 200 rim, having the 215 nm n~n3* slightly negative (Fig. 
3). In contrast, the latter spectral transition gives rise to a 
weakly positive band at 225 nm for Ac-RALPPLPRY-NH2, 
indicative of polyproline II helical conformation with trans 
Xaa-Pro bonds [27-32]. Similarly, Fig. 3 demonstrates a trend 
for decreasing negative molar ellipticities for peptide 1-5 in 
this spectral region when chain length increases. 
A 10-fold decrease in peptide concentration did not alter 
the CD spectra indicating that peptide association is not sig- 
nificant at the concentrations u ed for CD measurements. 
Temperature variations as well as denaturants may alter the 
relative amount of structured conformations contributing to 
the CD spectrum. A clear isodichroic point at 209 nm occurs 
recording the CD spectra of 5 at different emperatures from 
10°C to 85°C. The temperature dependence of the CD signal 
at 220 nm exhibits a different shape when determined for 
peptide 5 either in buffer solution or in 6.0 M guanidinium 
hydrochloride (GdmC1). The strictly linear plot of 0 220 with 
increasing temperature in GdmC1 contrasts with that obtained 
in buffer, which is bent downward (data not shown). Addi- 
tionally, the difference between the CD signal at 220 nm in the 
absence and presence of 6.0 M GdmC1 for peptide 1 is smaller 
than for peptide 5. Reversibility was demonstrated by the 
recovery of the original spectra fter cooling of the previously 
heated peptide solutions (Fig. 4). 
Furthermore, we could demonstrate that in spite of the 
various side chain functions the influence of the pH value 
on the CD spectra of 5 is negligible. The peptide solution 
was titrated from 7.5 to 2.1 or 10.8. Only a subtle decrease 
or increase, respectively, of the signals in the 200 nm region is 
observable without any change in overall spectral shape (re- 
suits not shown). Titration of these samples back to pH 7.5 
reversed this minor effect. 
~H-NMR studies have shown that peptide 5 has no stable 
secondary structure in aqueous olution (Reimer et al., in 
preparation). However, the left-handed polyproline II helix 
often found in peptides of related structure is so extended 
[33] that no special NOEs are detectable allowing a clear dis- 
tinction from unordered segments. 
4. Discussion 
The identification of a binding protein with the yeast two 
hybrid system requires quite tight interactions between the 
partner proteins. Similarly, co-purification or retardation in 
affinity chromatography may also function only for relatively 
stable complexes. The identification of the Pr55gag/Cyp18 in- 
teraction by these techniques established a quite high binding 
affinity of the proteins to each other. This finding is at var- 
iance with the high K,n values that could be separately deter- 
mined, in part, for cis and trans oligopeptide substrates cover- 
ing either the millimolar ange for trans isomers or slightly 
lower for the cis peptides [19,34]. Attempts to saturate par- 
tially Cypl8 in the enzyme catalyzed refolding of denatured 
RNase TI were also unsuccessful even at the highest protein 
concentrations used [35]. This substrate carries many potential 
subsites for disposal because it presents a trans to cis isomer- 
ization at the Ser-Pro 5~ peptide bond in the context of a 
partially unfolded polypeptide chain. 
The Pro 222 residue that was found to be critical in a genetic 
screen [16] was invariantly positioned in peptides 1-5. Ob- 
viously, by a knowledge-based model the heptapeptide 1 al- 
ready fulfils the structural requirements to act as an alterna- 
tive substrate within a Cypl8 assay. Indeed, 1H-NOESY 
spectra of 1 show additional cross-peaks as the result of mag- 
netization transfer in the presence of Cypl8 indicating enzy- 
matic catalysis of cis/trans isomerization [36,37]. Considering 
the slightly different conditions, e.g. the ratio of cis/trans iso- 
mers and solvent composition, the ICs0 value of 0.71 mM for 
1 (Table 1) fits the KI~ value of 1.2 + 0.4 mM measured for 
another peptide with the Gly-Pro moiety, the optimized stand- 
Table 1 
IC50 values of peptides 1-5 interacting with peptidyl prolyl cis/trans isomerases 
PPlase ~'b IC50 of 1 (mM) IC~0 of 2 (mM) IC~0 of 3 (raM) IC,~0 of 4 (mM) IC50 of 5 (raM) 
Cypl 8 0.71 _+ 0.03 1.6 + 0.08 1.3 + 0.06 1.30 + 0.05 0.18 + 0.01 
FKBP12 " ° ~ 1.12 _+ 0.04 1.6 -+ 0.06 
~All measurements using a protese-free assay in 0.05 mM HEPES pH 7.6 at 10°C, for details ee Section 2. 
Win the case of parvulin and trigger factor (both from E. coli) no detectable effect on peptidyl prolyl cis/trans isomerase activity was found up to 
final peptide concentrations of 0.6 mM. 
CThe enzymatic activity was not affected up to final peptide concentrations of 1.2 mM. 
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Fig. 4. Comparison of the CD-spectra of peptide l (dotted line), 
peptide 1 dissolved in 6 M GdrnC1 ([]), peptide 5 (solid line) and 
peptide 5 dissolved in 6 M GdmC1 (©). 
ard substrate Suc-Ala-Gly-Pro-Phe-4-nitroanilide. Similar to 
many proteolytic enzymes, cyclophilins require secondary 
binding sites in the peptide chain of substrates to express 
catalytic activity. It was often found that the presence of an 
appropriate linear stretch of amino acids adjacent to the reac- 
tion center was sufficient o represent the structural prerequi- 
site for lowering the activation energy for catalysis of both 
classes of enzymes. Whereas the nature of the amino acids in 
both positions N-terminally and C-terminally to proline does 
not contribute much to the second order rate constant kcatIKm 
of Cypl8 catalyzed reaction, chain length was found to be 
critical. Two amino acids preceding proline are required to 
establish minimal substrate properties, whereas a total of 5 
peptide bonds was required to maximize the kcat/Km value 
for Cypl8 catalysis [38,39]. Substrate binding is reflected 
more precisely by the Michaelis constant but data for peptides 
with different chain length were lacking. 
With respect o these data 1 has the characteristics of an 
optimal binder for Cypl 8. Indeed, although the probability of 
coming across prolines is higher and chain lengths are in- 
creased, the IC,~0 values of peptides 2--4 demonstrate a slightly 
reduced level of affinity. Failure of the numbers of proline 
residues alone to create high Cypl8 affinity was further shown 
by the formin-derived peptide Ac-ATPPPLPPPL-NH2 [40], 
which does not realize an efficient Cypl8 binder. This com- 
pound has a minor effect of 10% inhibition at 0.8 mM con- 
centration. Similarly, the same concentration of Ac- 
RALPPLPRY-NH2 did not affect the PPIase assay. Both 
compounds represent typical cognate peptides of WW 
[40,41] and SH3 domains [42,43], respectively, thought to be 
involved in mediating protein-protein i teractions by polypro- 
line recognition. In its non-acetylated state, the latter peptide 
(RALPPLPRY-NH2) binds to the Src SH3 domain with a Kd 
value of 8 ~tM [43]. In addition, regiospecificity of Cypl8 
catalysis caused by multiple proline sites was already found 
to occur [36]. 
Most interestingly, Cypl8 displays an enhancement in bind- 
ing only for a peptide covering all the prolines around Pro 222, 
as could be demonstrated by an ICs0 value of 0.18 mM for the 
25-mer peptide 5. Since the fractions of the individual cis/trans 
isomers occurring in aqueous olution of 5 are still unknown, 
the IC~0 value determined represents the lower binding limit 
for a discrete isomer. Due to the considerable chain length of 
5, affinity is less likely to increase by utilizing a larger number 
of subsites in a conventional way. As an alternative possibility 
it may happen that any cis/trans isomer of peptide 5 will form 
a certain type of peptide structure in solution. Recently, the 
three-dimensional structure of a proteolytic fragment of the 
core domain of the HIV-1 capsid protein containing amino 
acid residues Pro133-Leu 2s3 was solved by NMR spectroscopy 
[44]. Apart from seven helices the monomeric domain con- 
tains an exposed loop. The essential Glyzel-Pro 222 peptide 
bond is located on this loop, being specifically affected in its 
conformational state by a cisltrans equilibrium. Concerning 
the structural pattern of the protein segment excised, peptide 
5 encompasses the entire loop region including the type II ~- 
turn (Ala 224 through Gln 227) and helix V (Arg z32 through 
Ala237). 
However, substantial contributions of a random mixture of 
conformations may be inferred from the CD spectra of pep- 
tides 14.  Obviously, the CD spectrum of 5 is reminiscent of 
the truncated peptides lacking any indication for helical seg- 
ments. Furthermore, in the case of peptide 5 the curved plot 
of  0 220 with increasing temperature is consistent with a num- 
ber of partially ordered structures having different melting 
points. 
Recently, it was shown by NMR spectroscopy and crystal 
structure data for a 23-mer peptide APTMTRVLQGVL- 
PALPQVVCNYR, corresponding to the 38 60 fragment of 
the [3-subunit of human chorionic gonadotropin, that in aque- 
ous solution the majority of the residues adopted an extended 
polyproline II conformation [45]. The similarity of the central 
proline pair with that of 5 may suggest structural relatedness. 
The polyproline I! helix known to be formed from Ac- 
RALPPLPRY-NH2 [43] is clearly indicated by a positive 
CD signal at 225 nm, but cannot be found as a major con- 
formation in the spectra of 5 (Fig. 3). 
Clearly, further studies will have to elucidate the high af- 
finity prolyl bond conformation(s) of 5 by analyzing its com- 
position in solution with respect o the ratio of cis/trans iso- 
mers, and whether this particular isomer will be recognized as 
a substrate by the active site of Cypl8. 
As a recognition template this structure might be implicated 
in Cypl8 binding in vivo. Viral Cypl8 packaging shows that 
Pr55 gag interacts via its native state. However, native state 
Xaa-Pro cis/trans isomerization, known to exist for many pro- 
teins, has not yet been reported for an enzyme catalyzed rate 
acceleration [46]. As binding to the active site of Cypl8 is a 
prerequisite of catalysis, it still remains an open question 
whether the accessibility of the active cleft may allow Cypl8 
to accommodate a native protein. However, it is not possible 
to compare peptide 5 with both the Pr55 ~ and the fragment 
Pr24 cA in terms of binding constants because data for the 
proteins are not yet known. 
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